Carrillo-Esper R, Castillo-Albarrán FM, Pérez-Jáuregui J

Language: Spanish
References: 19
Page: 577-581
PDF size: 331.12 Kb.

ABSTRACT

Acute renal failure is a frequent complication in critically ill patients and is associated with high morbidity and mortality; therefore, its prophylaxis, diagnosis and intervention positively impact patient evolution. Neutrophil gelatinaseassociated lipocalin (NGAL) or lipocalin, a protein synthesized by renal tubular cells, has the property to transport lipophilic molecules such as vitamins, hormones and antigenic agents. It is a novel biomarker of acute kidney injury (AKI) of several etiologies and is increased in both serum and urine 48 h before the increase of creatinine. It has a strong correlation with early diagnosis of AKI. NGAL is of the most investigated and promising biomarkers for early diagnosis of AKI in different clinical scenarios, most notably in sepsis, cardiorenal syndrome, cardiac surgery, kidney transplant, contrast nephropathy and hemolytic uremic syndrome. Lipocalin guides the early institution of therapeutic interventions to improve prognosis in AKI of several etiologies.

REFERENCES

1. Bagshaw SM, George C, Bellomo R. Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care 2008;12:1-9.

2. Rodríguez LM, Roglan PA. Diagnóstico precoz del fracaso renal agudo. Med Intensiva 2010;34:291-293.

3. Alcázar R, De la Torre M, Santana H. Avances en la insuficiencia renal aguda en el año 2008. Nefrologia 2009;29:82-87.

4. Kümpers P, Hafer C, Lukasz A, Lichtinghagen R, Brand K, Fliser D, et al. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Crit Care 2010;14:1-9.

5. García GA. Reproducción y fertilidad humana: aspectos biomédicos de la familia de las lipocalinas. Repert Med Cir 2009;18:5-20.

6. García GA, Clavijo D, Mejía OR, García A, Vittorino M, Casadiego CA, et al. Aspectos biomédicos de la familia de las lipocalinas. Universitas Medica 2007;48:118-128.

7. Flower DR. The lipocalin protein family: structure and function. Biochem J 1996;318:1-14.

8. Flo TH, Smith KD, Sato S, Rodríguez DJ, Holmes MA, Strong RK, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004;432:917-921.

9. Yang J, Mori K, Li JY, Barach J. Iron, lipocalin, and kidney epithelia. Am J Physiol 2003;285:9-18.

10. Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, et al. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. Eur Heart J 2010;31:703–711.

11. Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest Suppl 2008;241:89–94.

12. Wheeler D, Devarajan P, Qing M, Harmon K, Monaco M, Cvijanovich N, et al. Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med 2008;36:1297-1303.

13. Devarajan P. NGAL in acute kidney injury: from serendipity to utility. Am J Kidney Dis 2008;52:395-399.

14. Zappitelli M, Washburn K, Arikan A, Loftis L, Qing M, Devarajan P. Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care 2007;11:1-11.

15. Mitsnefes M, Kathman T, Mishra J, Kartal J, Khoury PR, Nickolas T. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol 2007;22:101-108.

16. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio M, et. al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009;4:337-344.

17. Xu SY, Pauksen K, Venge P. Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand J Clin Lab Invest 1995;55:125-131.

18. Bagshaw S, Bennett M, Haase M, Haase-Fielitz A, Egi M, Morimatsu H. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med 2010;36:452-461.

19. Bohjörkqvist M, Kallman J, Fjaertoft G, Venge P, Schollin J. Human neutrophil lipocalin: normal levels and use as a marker for invasive infection in the newborn. Acta Pediatr 2004;4:534-539.